Home/PRD Therapeutics/Hiroshi Tomoda
HT

Hiroshi Tomoda

Outside Director, Co-Founder, Professor, Ph.D.

PRD Therapeutics

PRD Therapeutics Pipeline

DrugIndicationPhase
PRD001Homozygous Familial Hypercholesterolemia (HoFH)Phase 1
PRD002HoFH and MASH/MASLDDiscovery/Lead Optimization
PRD003Lysosomal Acid Lipase Deficiency (LAL-D)Discovery
PRD004DyslipidemiaDiscovery